Central Pharmaceutical Joint Stock Company No3 (HNX: DP3)
Vietnam
· Delayed Price · Currency is VND
57,300
-200 (-0.35%)
At close: Feb 4, 2025
HNX:DP3 Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Net Income | 121,172 | 125,263 | 108,824 | 94,305 | 114,061 | Upgrade
|
Other Operating Activities | -20,341 | 23,527 | -9,609 | -67,997 | 8,301 | Upgrade
|
Operating Cash Flow | 100,830 | 148,790 | 99,215 | 26,308 | 122,361 | Upgrade
|
Operating Cash Flow Growth | -32.23% | 49.97% | 277.13% | -78.50% | 312.20% | Upgrade
|
Capital Expenditures | -1.61 | -4,499 | -15,089 | -446.26 | -68,243 | Upgrade
|
Sale of Property, Plant & Equipment | - | 1,824 | - | - | - | Upgrade
|
Other Investing Activities | 7,657 | 17,521 | 8,814 | 6,324 | 10,555 | Upgrade
|
Investing Cash Flow | -19,332 | -100,775 | -54,654 | 25,878 | -72,688 | Upgrade
|
Short-Term Debt Issued | - | 15,110 | 15,414 | 10,210 | 64,043 | Upgrade
|
Long-Term Debt Issued | 10,700 | - | - | - | - | Upgrade
|
Total Debt Issued | 10,700 | 15,110 | 15,414 | 10,210 | 64,043 | Upgrade
|
Short-Term Debt Repaid | - | - | -12,222 | -12,060 | -67,124 | Upgrade
|
Long-Term Debt Repaid | -18,475 | -12,565 | -1,490 | - | - | Upgrade
|
Total Debt Repaid | -18,475 | -12,565 | -13,712 | -12,060 | -67,124 | Upgrade
|
Net Debt Issued (Repaid) | -7,775 | 2,545 | 1,702 | -1,850 | -3,081 | Upgrade
|
Common Dividends Paid | -65,397 | -66,293 | -49,885 | -66,529 | -60,180 | Upgrade
|
Financing Cash Flow | -73,172 | -63,748 | -48,183 | -68,379 | -63,260 | Upgrade
|
Foreign Exchange Rate Adjustments | 5.24 | 2.19 | 25.84 | 2.48 | -3.51 | Upgrade
|
Net Cash Flow | 8,332 | -15,731 | -3,596 | -16,191 | -13,590 | Upgrade
|
Free Cash Flow | 100,829 | 144,292 | 84,126 | 25,862 | 54,119 | Upgrade
|
Free Cash Flow Growth | -30.12% | 71.52% | 225.29% | -52.21% | 82.58% | Upgrade
|
Free Cash Flow Margin | 24.15% | 35.22% | 17.34% | 6.79% | 13.68% | Upgrade
|
Free Cash Flow Per Share | 4689.79 | 6711.00 | 3717.11 | 1202.91 | 2517.18 | Upgrade
|
Cash Interest Paid | 9.14 | 1,488 | 2,868 | 1,207 | 1,976 | Upgrade
|
Cash Income Tax Paid | 31,740 | 27,665 | 24,159 | 29,399 | 25,854 | Upgrade
|
Levered Free Cash Flow | 65,584 | 115,574 | 60,230 | 55,727 | 33,431 | Upgrade
|
Unlevered Free Cash Flow | 65,685 | 116,571 | 64,277 | 56,008 | 34,662 | Upgrade
|
Change in Net Working Capital | 19,740 | -35,517 | 521.53 | 13,632 | -19,572 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.